Chief Financial Officer Bonstein Sara sale 57,765 shares of Insmed Inc [INSM]

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Insmed Inc shares valued at $5,879,089 were sold by Bonstein Sara on Jun 23 ’25. At $101.78 per share, Bonstein Sara sold 57,765 shares. The insider’s holdings dropped to 93,536 shares worth approximately $9.81 million following the completion of this transaction.

Also, Bonstein Sara purchased 57,765 shares, netting a total of over 5,877,434 in proceeds.

Before that, Wise John Drayton had added 20,000 shares to its account. In a trade valued at $2,099,400, the Former Officer bought Insmed Inc shares for $104.97 each.

As published in their initiating research note from Jefferies on May 13, 2025, Insmed Inc [INSM] has been a Buy and the price target has been revised to $105. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in late February. As of April 23, 2024, Truist has initiated its “Buy” rating for INSM. Earlier on February 15, 2024, Wolfe Research initiated its rating. Their recommendation was “an Outperform” for INSM stock.

Analyzing INSM Stock Performance

On last trading session,, Insmed Inc [NASDAQ: INSM] plunged -0.99% to $104.85. The stock’s lowest price that day was $104.06, but it reached a high of $106.83 in the same session. During the last five days, there has been a surge of approximately 4.56%. Over the course of the year, Insmed Inc shares have jumped approximately 54.21%. Shares of the company reached a 52-week high of $106.83 on 06/25/25 and a 52-week low of $60.40 on 04/09/25.

Support And Resistance Levels for Insmed Inc (INSM)

According to the 24-hour chart, there is a support level at 103.66, which, if violated, would cause prices to drop to 102.48. In the upper region, resistance lies at 106.43. The next price resistance is at 108.02. RSI (Relative Strength Index) is 78.07 on the 14-day chart, showing overbought technical sentiment.

Is Insmed Inc subject to short interest?

Stocks of Insmed Inc saw a sharp rise in short interest on 2025-05-30 jumping by 1.68 million shares to 17.46 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 15.78 million shares. A jump of 9.62% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.75 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.75.

Which companies own the most shares of Insmed Inc (INSM)?

In terms of Insmed Inc share price expectations, FactSet research, analysts set an average price target of 110 in the next 12 months, up nearly 3.87% from the previous closing price of $105.9. Analysts anticipate Insmed Inc stock to reach 110 by 2025, with the lowest price target being 110. In spite of this, 14 analysts ranked Insmed Inc stock as Buy at the end of 2025. On December 08, 2023, Wells Fargo assigned a price target of “an Overweight” to the stock and initiated coverage with a $55.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.